Press-release for stocks for gilead sciences, inc.

| -0.84% | O: 0.14% H: 1.05% C: -0.99%
yescarta treatment for t-cell granted authorization therapy

Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
Published: 2022-06-25 (Crawled : 12:20) - globenewswire.com
GILD | News | $62.21 -0.99% -0.31% |

| Email alert Add to watchlist
VIR S | $25.73 -3.45% 0.0% |

| Email alert Add to watchlist
ALNY | $142.2 -2.93% 0.0% |

| Email alert Add to watchlist
hepatitis program

Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV
Published: 2022-06-24 (Crawled : 13:00) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| 0.63% | O: 1.52% H: 0.0% C: 0.0%
for chmp hiv positive

Treatment With Hepcludex® (Bulevirtide) Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks
Published: 2022-06-23 (Crawled : 16:00) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| 1.14% | O: 0.5% H: 0.0% C: 0.0%
hepcludex treatment hepatitis virus response

Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress™ 2022
Published: 2022-06-21 (Crawled : 14:00) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| 6.29% | O: 1.34% H: 0.0% C: 0.0%
liver disease international

Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom
Published: 2022-06-16 (Crawled : 11:00) - biospace.com/
HGEN | $1.93 -6.31% -0.52% |

| -12.67% | O: 0.45% H: 0.0% C: -3.6%
GILD | News | $62.21 -0.99% -0.31% |

| 6.54% | O: -1.25% H: 0.82% C: 0.1%
pharma services for commercialization

Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer
Published: 2022-06-10 (Crawled : 04:00) - prnewswire.com
GILD | News | $62.21 -0.99% -0.31% |

| -0.13% | O: -2.99% H: 0.0% C: 0.0%
trodelvy for approval china cancer breast cancer

Lyndra Therapeutics Doses First Clinical Trial Participant in Study of Oral Biweekly Ivermectin (LYN-163) as a Tool in the Fight to Eradicate Malaria
Published: 2022-06-09 (Crawled : 14:00) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| -0.27% | O: -0.14% H: 0.0% C: 0.0%
lyn-163 trial therapeutics

Final Data From Phase 3 ASCENT Study Demonstrates Trodelvy Extends Overall Survival Over Chemotherapy in Second-Line Metastatic TNBC
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| -1.82% | O: -1.24% H: 0.71% C: -0.87%
trodelvy

Everest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients
Published: 2022-06-04 (Crawled : 16:20) - prnewswire.com
GILD | News | $62.21 -0.99% -0.31% |

| Email alert Add to watchlist
cs-02 trodelvy sciences positive results cancer breast cancer

Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
Published: 2022-06-03 (Crawled : 22:00) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| -3.79% | O: -2.01% H: 0.0% C: 0.0%
yescarta t-cell therapy

Celularity Appoints Industry Leader Diane Parks to its Board of Directors
Published: 2022-06-03 (Crawled : 12:20) - globenewswire.com
ABBV | News | $152.49 -0.42% -0.06% |

| 4.47% | O: 0.54% H: 0.99% C: 0.29%
KURA A | $17.46 0.63% 0.0% |

| 31.33% | O: 1.09% H: 2.08% C: 0.97%
GILD | News | $62.21 -0.99% -0.31% |

| -3.79% | O: -2.01% H: 0.0% C: 0.0%
CELU | $3.23 -10.53% -0.62% |

| -68.38% | O: 1.52% H: 7.43% C: 4.53%
SNGX | News | $0.5413 -2.28% -0.43% |

| 0.56% | O: -3.4% H: 7.67% C: -1.65%
CTIC | $5.54 -1.77% -0.72% |

| -7.2% | O: 1.01% H: 2.9% C: -4.64%
CALT | News | $17.735 -5.67% 1.49% |

| -7.24% | O: 1.57% H: 0.0% C: -1.3%
AMGN | $243.51 -0.55% -0.13% |

| -3.65% | O: -1.43% H: 0.0% C: 0.0%

Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium
Published: 2022-06-03 (Crawled : 12:00) - biospace.com/
HOOK | $1.59 -5.36% 0.0% |

| -6.47% | O: 0.59% H: 0.0% C: 0.0%
GILD | News | $62.21 -0.99% -0.31% |

| -3.79% | O: -2.01% H: 0.0% C: 0.0%
preclinical hiv symposium pre-clinical

Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| -3.95% | O: -0.17% H: 0.0% C: 0.0%
sciences

Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
Published: 2022-05-24 (Crawled : 01:00) - biospace.com/
CWBR | $0.174 -1.75% 5.17% |

| -3.33% | O: 0.17% H: 5.38% C: -0.17%
KODK | $5.09 -4.32% -0.98% |

| 17.28% | O: -2.76% H: 0.0% C: 0.0%
GILD | News | $62.21 -0.99% -0.31% |

| -2.28% | O: 0.27% H: 0.0% C: 0.0%

Second Genome Presents New Data at Digestive Disease Week (DDW) 2022 Demonstrating that SG-5-00455, a Potential First-in-Class Precision Therapeutic, Improves Epithelial Barrier Function and Promotes Mucosal Healing in Inflammatory Bowel Disease
Published: 2022-05-24 (Crawled : 20:00) - prnewswire.com
GILD | News | $62.21 -0.99% -0.31% |

| -2.54% | O: 0.97% H: 1.15% C: 0.87%
disease week potential

Eikon Therapeutics Announces the Election of Robin L. Washington to Its Board of Directors
Published: 2022-05-16 (Crawled : 12:00) - biospace.com/
GOOGL | News C | $2240.15 -3.3% -0.01% |

| -1.81% | O: 0.93% H: 0.0% C: 0.0%
GILD | News | $62.21 -0.99% -0.31% |

| -0.62% | O: -0.37% H: 0.59% C: -0.21%
CRM | News M | $171.46 -5.43% -0.27% |

| 10.19% | O: 0.69% H: 0.0% C: 0.0%
GOOG | News | $2251.43 -3.47% 0.04% |

| -1.53% | O: 1.57% H: 0.0% C: 0.0%
therapeutics

BioSpace Movers & Shakers: Singular Genomics, Marengo, Ventyx, Caribou and More
Published: 2022-05-13 (Crawled : 13:20) - biospace.com/
LH | News | $235.96 -2.22% -0.37% |

Health Services

| 2.34% | O: 3.38% H: 1.21% C: -0.17%
ONCR A | $1.35 0.75% -6.67% |

| 18.42% | O: 6.14% H: 4.89% C: -4.13%
GILD | News | $62.21 -0.99% -0.31% |

| 2.37% | O: 3.01% H: 0.0% C: 0.0%
BWAY | News | $5.06 -2.69% 0.99% |

| -12.0% | O: -7.83% H: 2.83% C: 2.83%

MOBIfest Presented by Gilead Sciences, Inc. Returns to New York with Collection of Celebrations and Experiences June 5 - 12
Published: 2022-05-12 (Crawled : 14:20) - prnewswire.com
GILD | News | $62.21 -0.99% -0.31% |

| 2.72% | O: 0.35% H: 0.0% C: 0.0%

Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation
Published: 2022-05-02 (Crawled : 14:00) - biospace.com/
GILD | News | $62.21 -0.99% -0.31% |

| 4.84% | O: 0.35% H: 1.47% C: 1.28%
research collaboration

← Previous
1
2
3
4
5
6
7
8
9
…
13
14
Next →

Your saved searches

Save your searches and get alerts when important news are released.

Mentioned Today

ABB | News | $26.87 -0.85% 0.45% |

ABLZF | News | $28.0 1.08% |

ACN | News | $283.8 -3.01% -0.99% |

AKAM | News | $92.39 -2.25% 0.5% |

ALPMF | News | $16.71 5.56% |

ALPMY | News | $16.14 1.19% |

APH | News | $64.72 -2.12% 0.0% |

ARVL | News | $1.61 -4.73% 0.0% |

BHC | News 4 | $8.83 1.73% -0.57% |

BNPQF | News | $49.65 -4.65% |

BNPQY | News | $24.99 -0.99% |

Finance and Insurance

BNPZY | News | $ 0% |

Finance and Insurance

BTG | News | $3.55 -3.01% 0.0% |

Non-Energy Minerals

CERN | News | $94.92 0.03% |

CGNT | News | $4.58 -28.66% 2.4% |

CGNX | News | $44.63 -1.85% -2.31% |

CLH | News | $87.8 0.92% 0.0% |

COLD | News | $30.06 -0.76% 0.0% |

COP | News | $95.22 3.24% -0.2% |

Energy Minerals

CRCW | News | $0.965 1.58% |

Information

CREE | News | $80.07 0% |

CRM | News 4 | $171.46 -5.43% -0.27% |

CSCO | News | $43.06 -1.62% 0.09% |

CTXS | News | $96.15 -0.63% 0.0% |

CVLT | News | $63.29 -2.78% 0.0% |

CW | News | $131.15 -0.67% 0.0% |

DELL | News | $48.94 -2.59% 0.0% |

DGII | News | $23.3 -4.04% 0.0% |

DHR | News | $251.88 -1.77% 0.0% |

DKILF | News | $157.75 -5.18% |

DKILY | News | $16.18 0.81% |

ECOM | News | $14.68 1.17% 4.97% |

ERIC | News | $7.78 -2.14% -0.39% |

ESLT | News | $210.38 1.14% 0.0% |

ETNB | News | $3.55 3.2% -4.79% |

EVH | News | $30.94 -2.74% 0.0% |

FCN | News | $172.21 -1.22% 0.0% |

FLIR | News | $57.34 0% |

GBERF | News | $546.0 |

GBERY | News | $48.7 -1.6% |

GE | News | $65.88 -1.24% 0.47% |

GLAXF | News | $21.99 4.22% |

GLPI | News | $46.68 -0.09% -3.06% |

GSK | News | $43.35 -0.8% -0.09% |

GXO | News | $45.5 -1.22% 2.13% |

HNI | News | $35.65 -2.33% 0.0% |

HON | News | $175.95 -1.31% 0.03% |

HY | News | $33.35 -3.42% 0.0% |

IKTSF | News | $59.175 |

Professional, Scientific, and T...

IKTSY | News | $53.97 0.26% |

INCY | News | $75.63 -2.24% -0.99% |

INTU | News 4 | $386.29 -4.55% 0.0% |

IRCP | News | $2.4984 0.06% |

JCI | News | $48.44 -0.43% 0.0% |

JTEKF | News | $ 0% |

JTEKY | News | $24.29 |

LEA | News | $134.75 0.57% 0.0% |

LHX | News | $235.82 -0.42% 0.0% |

LLY | News 4 | $317.62 -2.95% -0.47% |

LMT | News | $420.71 0.35% -0.17% |

MASI | News | $137.07 -1.95% 0.0% |

MCFUF | News | $4.105 |

MCK | News 4 | $321.55 -1.44% -0.02% |

Distribution Services

MDRX | News 4 | $15.33 -2.23% 0.0% |

MDT | News | $89.2 -1.4% -0.1% |

MSFT | News | $256.48 -3.18% 0.06% |

MTX | News | $61.47 -0.87% 0.0% |

Process Industries

NDAQ | News 4 | $154.66 -2.07% -1.61% |

NIO | News | $22.36 -2.57% -6.57% |

Consumer Durables

NIPNF | News | $38.0 |

NOC | News | $464.67 -0.46% 0.74% |

NUVB | News | $3.55 -2.47% 0.0% |

NVS | News | $84.17 -1.3% 0.17% |

NVSEF | News | $84.85 1.0% |

ORCL | News 4 | $68.58 -2.6% 1.43% |

PCRFF | News | $8.217 0.82% |

n/a

PCRFY | News | $8.16 -0.73% |

n/a

PPRUF | News | $544.41 1.95% |

Consumer Non-Durables

PPRUY | News | $52.31 0.13% |

RELX | News | $26.77 -1.91% 0.26% |

RLXXF | News | $26.94 -1.93% |

RNGR | News | $10.28 -0.48% 0.0% |

ROK | News | $197.64 -1.82% 0.0% |

RSG | News 4 | $127.91 -1.15% 0.0% |

RYLPF | News | $21.425 -2.83% |

SAP | News | $95.47 -1.88% -0.8% |

SAPGF | News | $97.382 -1.0% |

SBGSF | News | $124.59 -1.9% |

SBGSY | News | $24.426 -0.99% |

SEKEF | News | $15.184 -6.47% |

SEKEY | News | $7.34 -0.74% |

SNNUF | News | $15.05 4.44% |

TEL | News | $114.92 -2.24% 0.0% |

TEVJF | News | $8.34 0.48% |

TMO | News | $535.77 -1.45% -1.84% |

TRI | News | $101.23 -2.95% 0.0% |

UL | News | $45.33 -1.46% 0.0% |

Consumer Non-Durables

UNLYF | News | $45.805 -3.0% |

Consumer Non-Durables

VEON | News | $0.4567 -0.74% 0.42% |

Communications

VMW | News | $116.25 -1.2% 0.0% |

VSH | News | $18.22 -0.92% 0.0% |

VTRS | News | $10.9 -1.54% 1.19% |

WFC | News 4 | $40.18 -0.15% 0.25% |

WKEY | News | $2.68 -5.63% 2.24% |

WM | News | $148.88 -0.43% -0.08% |

XYL | News 4 | $77.9 -2.07% 0.0% |

ZTS | News 4 | $170.12 -2.01% 0.96% |

ZUO | News 4 | $9.3 -5.3% 0.0% |